• A study to evaluate the safety and effectiveness of PTT-4256 and nivolumab in patients with solid tumors.

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Spain

  • A study of DS-3790A, rituximab, and epcoritamab in patients with blood cancers

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    France Italy

  • A study to evaluate the effectiveness of upadacitinib and pirfenidone in reducing symptom severity in patients with Long Covid

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • A study of canagliflozin and 18F-canagliflozin in patients with chronic kidney disease undergoing dialysis

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    The Netherlands

  • Comparing the effect of romosozumab and denosumab on coronary artery damage in women with postmenopausal osteoporosis

    Not yet recruiting

    3 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • Study of the effectiveness and safety of alpha-lipoic acid and benfotiamine for the treatment of symptoms in patients with diabetic neuropathy

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Hungary

  • A study to evaluate the long-term safety and effectiveness of sonelokimab in patients with psoriatic arthritis

    Not yet recruiting

    3 1 1
    Investigated diseases:
    Investigated drugs:
    Bulgaria Croatia Czechia Estonia Finland France +10

  • A study to evaluate if silymarin prevents liver damage caused by ribociclib in patients with hormone receptor positive, HER2-negative breast cancer

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Investigated drugs:
    Italy

  • A study to evaluate the safety and effectiveness of H-CYS(SS)-GLU-VAL-SER-GLN-LEU-LEU-LYS-GLY-ASP-ALA-CYS(SS)-OH in patients with advanced solid tumors who have completed other treatments.

    Not yet recruiting

    2 1 1
    Investigated diseases:
    Belgium France

  • A study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn’s disease

    Not yet recruiting

    3 1
    Investigated diseases:
    Investigated drugs:
    Austria Belgium Bulgaria Czechia France Germany +9

powered by